Psychometric validation of the European Organisation for Research and Treatment of Cancer– Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22) (CROSBI ID 320879)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Greimel, Elfriede ; Nagele, Eva ; Lanceley, Anne ; Oberguggenberger, Anne S. ; Nordin, Andy ; Kuljanić, Karin ; Arraras, Juan I. ; Wei-Chu, Chie ; Jensen, Pernille T. ; Tomaszewski, Krzysztof A. ; Creutzberg, Carien L. ; Galalae, Razvan ; Toelen, Hilde ; Zimmermann, Kristin ; Bjelic- Radisic, Vesna ; Costantini, Anna ; Almont, Thierry ; Serpentini, Samantha ; Paskeviciute Frøding, Ligita ; Vistad, Ingvild ; Schmalz, Claudia
engleski
Psychometric validation of the European Organisation for Research and Treatment of Cancer– Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)
Background: The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group developed a questionnaire to assess sexual health in patients with cancer and cancer survivors. This study evaluates the psychometric properties of the questionnaire. Methods: The 22-item EORTC sexual health questionnaire (EORTC QLQ-SH22) was administered with the EORTC QLQ-C30 to 444 patients with cancer. The hypothesised scale structure, reliability and validity were evaluated through standardised psychometric procedures. Results: The cross-cultural field study showed that the majority of patients (94.7%) were able to complete the QLQ-SH22 in less than 20 min ; 89% of the study participants did not need any help to fill in the questionnaire. Multi-item multi-trait scaling analysis confirmed the hypothesised scale structure with two multi-item scales (sexual satisfaction, sexual pain) and 11 single items (including five conditional items and four gender- specific items). The internal consistency yielded acceptable Cronbach's alpha coefficients (.90 for the sexual satisfaction scale, .80 for the sexual pain scale). The test-retest correlations (Pearson's r) ranged from .70 to .93 except for the scale communication with professionals (.67) and male body image (.69). The QLQ-SH22 discriminates well between subgroups of patients differing in terms of their performance and treatment status. Conclusion: The study supports the reliability, the content and construct validity of the QLQ- SH22. The newly developed questionnaire is clinically applicable to assess sexual health of patients with cancer at different treatment stages and during survivorship for clinical trials and for clinical practice.
Cancer ; Cross-cultural validation ; EORTC ; Psychometric properties ; Quality of life ; Questionnaire development ; Sexual health
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti, Psihologija